Teriparatide inhalation - Alkermes

Drug Profile

Teriparatide inhalation - Alkermes

Alternative Names: AIR PTH; AIR® parathyroid hormone; AIR® PTH [1-34]; AIR® teriparatide; Teriparatide AIR®

Latest Information Update: 07 Oct 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alkermes
  • Class Osteoporosis therapies; Peptide hormones; Skin disorder therapies
  • Mechanism of Action Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Postmenopausal osteoporosis

Most Recent Events

  • 21 Oct 2013 Biomarkers information updated
  • 08 Jun 2007 Phase-I clinical trials in Postmenopausal osteoporosis in USA (Inhalation)
  • 10 Jan 2006 Preclinical trials in Postmenopausal osteoporosis in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top